Auranofin coated catheters inhibit bacterial and fungal biofilms in a murine subcutaneous model
暂无分享,去创建一个
B. Fuchs | E. Mylonakis | Biswajit Mishra | A. Shukla | Nagendran Tharmalingam | LewisOscar Felix | Noel Vera-González | Cutler B. Whitely
[1] H. Ağın,et al. Changes in the incidence of Candida-related central line-associated bloodstream infections in pediatric intensive care unit: Could central line bundle have a role? , 2022, Journal de mycologie medicale.
[2] M. Rupp,et al. Prevention of Central-Line Associated Bloodstream Infections: 2021 Update. , 2021, Infectious disease clinics of North America.
[3] Jill Harris,et al. A Review of Best Practices Related to Intravenous Line Management for Nurses. , 2021, The Nursing Clinics of North America.
[4] R. Wolcott. Biofilm and catheter-related bloodstream infections. , 2021, British journal of nursing.
[5] B. Fuchs,et al. Thioredoxin Reductase Is a Valid Target for Antimicrobial Therapeutic Development Against Gram-Positive Bacteria , 2021, Frontiers in Microbiology.
[6] A. Pugazhendhi,et al. In vitro analysis of green fabricated silver nanoparticles (AgNPs) against Pseudomonas aeruginosa PA14 biofilm formation, their application on urinary catheter , 2021 .
[7] A. Shetty,et al. Therapeutic implications of C. albicans-S. aureus mixed biofilm in a murine subcutaneous catheter model of polymicrobial infection , 2021, Virulence.
[8] J. Lopez-Ribot,et al. Inhibition of Mixed Biofilms of Candida albicans and Methicillin-Resistant Staphylococcus aureus by Positively Charged Silver Nanoparticles and Functionalized Silicone Elastomers , 2020, Pathogens.
[9] A. Pugazhendhi,et al. Biofilm and Quorum sensing mediated pathogenicity in Pseudomonas aeruginosa , 2020 .
[10] A. Grumezescu,et al. Recent Advances in Surface Nanoengineering for Biofilm Prevention and Control. Part II: Active, Combined Active and Passive, and Smart Bacteria-Responsive Antibiofilm Nanocoatings , 2020, Nanomaterials.
[11] P. Zimmern,et al. Advances in Understanding the Human Urinary Microbiome and Its Potential Role in Urinary Tract Infection , 2020, mBio.
[12] Yong Wu,et al. Antibiofilm efficacy of the gold compound auranofin on dual species biofilms of Staphylococcus aureus and Candida sp. , 2020, Journal of applied microbiology.
[13] Huan Yu,et al. One-step hydrophobization of tannic acid for antibacterial coating on catheters to prevent catheter-associated infections. , 2019, Biomaterials science.
[14] B. Peters,et al. Candida albicans and Staphylococcus aureus Pathogenicity and Polymicrobial Interactions: Lessons beyond Koch’s Postulates , 2019, Journal of fungi.
[15] I. Jacobsen,et al. Fungal-Bacterial Interactions in Health and Disease , 2019, Pathogens.
[16] B. Fuchs,et al. Auranofin Releasing Antibacterial and Antibiofilm Polyurethane Intravascular Catheter Coatings , 2019, Front. Cell. Infect. Microbiol..
[17] K. Riedel,et al. Session 2: Biofilms/Implant associated infections , 2019, Biomedizinische Technik. Biomedical engineering.
[18] Siheng Li,et al. Antimicrobial strategies for urinary catheters. , 2018, Journal of biomedical materials research. Part A.
[19] Rui-tao Wang,et al. Effectiveness of antimicrobial-coated central venous catheters for preventing catheter-related blood-stream infections with the implementation of bundles: a systematic review and network meta-analysis , 2018, Annals of Intensive Care.
[20] B. Arulanandam,et al. Repurposing Auranofin, Ebselen, and PX-12 as Antimicrobial Agents Targeting the Thioredoxin System , 2018, Front. Microbiol..
[21] S. Alharbi,et al. In vitro and in silico attenuation of quorum sensing mediated pathogenicity in Pseudomonas aeruginosa using Spirulina platensis. , 2018, Microbial pathogenesis.
[22] D. Steinberg,et al. Chlorhexidine sustained‐release varnishes for catheter coating – Dissolution kinetics and antibiofilm properties , 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[23] C. Nielsen,et al. Catheter‐Associated Urinary Tract Infections: Implementing a protocol to decrease incidence in oncology populations , 2017, Clinical journal of oncology nursing.
[24] G. Donelli,et al. Antifouling and antimicrobial biomaterials: an overview , 2017, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[25] Jason Locklin,et al. A review of the recent advances in antimicrobial coatings for urinary catheters. , 2017, Acta biomaterialia.
[26] A. Srinivasan,et al. Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungi , 2017, Virulence.
[27] T. Hazbun,et al. Repurposing Approach Identifies Auranofin with Broad Spectrum Antifungal Activity That Targets Mia40-Erv1 Pathway , 2017, Front. Cell. Infect. Microbiol..
[28] P. Thomsen,et al. Co-release of dicloxacillin and thioridazine from catheter material containing an interpenetrating polymer network for inhibiting device-associated Staphylococcus aureus infection. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[29] K. Leung,et al. Screening a Commercial Library of Pharmacologically Active Small Molecules against Staphylococcus aureus Biofilms , 2016, Antimicrobial Agents and Chemotherapy.
[30] G. Guebitz,et al. Antifouling and Antibacterial Multifunctional Polyzwitterion/Enzyme Coating on Silicone Catheter Material Prepared by Electrostatic Layer-by-Layer Assembly. , 2016, Langmuir : the ACS journal of surfaces and colloids.
[31] L. Rice,et al. Inhibition of bacterial and fungal pathogens by the orphaned drug auranofin. , 2016, Future medicinal chemistry.
[32] P. Wells,et al. Urinary catheters: history, current status, adverse events and research agenda , 2015, Journal of medical engineering & technology.
[33] Peter G. Schultz,et al. Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis , 2015, Proceedings of the National Academy of Sciences.
[34] S. Gorman,et al. Biofilms and implant-associated infections , 2014 .
[35] S. Anupurba,et al. Catheter-related bloodstream infections , 2014, International journal of critical illness and injury science.
[36] Tianhong Dai,et al. Blue light eliminates community-acquired methicillin-resistant Staphylococcus aureus in infected mouse skin abrasions. , 2013, Photomedicine and laser surgery.
[37] S. Ünal,et al. Central venous catheter-related biofilm infections: An up-to-date focus on meticillin-resistant Staphylococcus aureus. , 2013, Journal of global antimicrobial resistance.
[38] Anand K. Ramasubramanian,et al. High-Throughput Screening of a Collection of Known Pharmacologically Active Small Compounds for Identification of Candida albicans Biofilm Inhibitors , 2013, Antimicrobial Agents and Chemotherapy.
[39] Kristine M. Thompson,et al. Intravascular Catheter-Related Bloodstream Infection , 2013, The Neurohospitalist.
[40] P. Marik,et al. The risk of catheter-related bloodstream infection with femoral venous catheters as compared to subclavian and internal jugular venous catheters: A systematic review of the literature and meta-analysis* , 2012, Critical care medicine.
[41] M. Harriott,et al. Importance of Candida-bacterial polymicrobial biofilms in disease. , 2011, Trends in microbiology.
[42] B. Peters,et al. Microbial interactions and differential protein expression in Staphylococcus aureus –Candida albicans dual-species biofilms , 2010, FEMS immunology and medical microbiology.
[43] G. Robertson,et al. Bacterial and fungal biofilm infections. , 2008, Annual review of medicine.
[44] A. Mitchell,et al. Regulation of Cell-Surface Genes and Biofilm Formation by the C. albicans Transcription Factor Bcr1p , 2005, Current Biology.
[45] E Moser,et al. High‐resolution blood flow velocity measurements in the human finger , 2001, Magnetic resonance in medicine.
[46] R. M. Donlan,et al. Biofilms and device-associated infections. , 2001, Emerging infectious diseases.
[47] M. Ghannoum,et al. Antifungal Resistance of Candidal Biofilms Formed on Denture Acrylic in vitro , 2001, Journal of dental research.
[48] Maneesha K. Suresh,et al. An update on recent developments in the prevention and treatment of Staphylococcus aureus biofilms. , 2019, International journal of medical microbiology : IJMM.
[49] F. Marchlinski,et al. Catheter Ablation of Idiopathic Ventricular Arrhythmias. , 2019, Heart, lung & circulation.
[50] M. Jabra-Rizk,et al. Fungal–Bacterial Interactions: In Health and Disease , 2017 .
[51] I. Raad,et al. Biofilm-based central line-associated bloodstream infections. , 2015, Advances in experimental medicine and biology.
[52] Peng Li,et al. Antimicrobial functionalization of silicone surfaces with engineered short peptides having broad spectrum antimicrobial and salt-resistant properties. , 2014, Acta biomaterialia.
[53] Sanjay Saint,et al. Guidelines for the prevention of intravascular catheter-related infections. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[54] L. J. Douglas,et al. Candida biofilms and their role in infection. , 2003, Trends in microbiology.
[55] Donald L. Miller,et al. Guidelines for the prevention of intravascular catheter-related infections: recommendations relevant to interventional radiology. , 2003, Journal of vascular and interventional radiology : JVIR.
[56] T. Maira-Litrán,et al. The physiology and collective recalcitrance of microbial biofilm communities. , 2002, Advances in microbial physiology.
[57] G. O’Toole,et al. Mechanisms of biofilm resistance to antimicrobial agents. , 2001, Trends in microbiology.